ÂÜÀòÂÒÂ×

Ornela Gjata is an experienced professional currently serving as the Associate Director of Clinical Product Risk at Boston Scientific, with a focus on Peripheral Interventions and Interventional Oncology. Over a career that began in 2008, Ornela has held various positions within Boston Scientific, including Clinical Program Manager and Clinical Project Manager, where responsibilities included leading strategic initiatives, managing clinical study protocols, and overseeing financial strategies for project budgets. Prior to Boston Scientific, Ornela worked as a Clinical Research Coordinator at Brigham and Women's Hospital and conducted research at prestigious institutions such as Harvard Stem Cell Institute. Ornela holds a Master's Degree in Biological Sciences from Harvard University and a Bachelor's Degree in Biology from George Mason University. Additionally, Ornela has a strong background in interpretation and translation, complemented by hands-on clinical experience as a Care Team Clinical Technician at Inova Health System.